LEO Pharma Bolsters Rare Skin Disease Focus Through Acquisition of Replay Gene Therapy Platform – Business Wire
LEO Pharma Bolsters Rare Skin Disease Focus Through buyout of Replay Gene Therapy Platform Business Wire Source: news.google.com
LEO Pharma Bolsters Rare Skin Disease Focus Through buyout of Replay Gene Therapy Platform Business Wire Source: news.google.com
Chiesi Group to buy KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio Business Wire Source: news.google.com
Ligand Pharma to buy fellow biotech royalty rights buyer XOMA for $739 million Reuters Source: news.google.com
Sun Pharma signs Definitive pact to buy Organon Business Wire Source: news.google.com
Servier completes the buyout of Day One Biopharmaceuticals PR Newswire Source: news.google.com
Kashiv BioSciences Agrees to Be bought by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader Business Wire Source: news.google.com
Asahi Kasei Completes buyout of Aicuris to Advance Its Global Pharmaceutical Strategy Business Wire Source: news.google.com
Great American Food Chain (OTC: GAMN) Completes combination with GreenMatter Biotech, Names Joe H. Wicker Jr. CEO GlobeNewswire Source: news.google.com
Premier Biotech Adds Scale in Point-of-Care Testing with GH Solutions buyout Business Wire Source: news.google.com
GTCR Completes buyout of Zentiva, a Leading European Generics Pharmaceutical firm PR Newswire Source: news.google.com